Enanta Pharmaceuticals, Inc. (ENTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 280.32M |
| Enterprise value | -31.34M |
| Trailing P/E | 436.70 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.79 |
| Price/book (mrq) | 1.46 |
| Enterprise value/revenue | -0.43 |
| Enterprise value/EBITDA | 0.25 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.49 |
| 52-week change 3 | -62.14% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 37.27 |
| 52-week low 3 | 8.08 |
| 50-day moving average 3 | 14.74 |
| 200-day moving average 3 | 12.82 |
Share statistics
| Avg vol (3-month) 3 | 226.15k |
| Avg vol (10-day) 3 | 123.24k |
| Shares outstanding 5 | 21.16M |
| Implied shares outstanding 6 | 21.16M |
| Float 8 | 13.34M |
| % held by insiders 1 | 6.10% |
| % held by institutions 1 | 100.17% |
| Shares short (15 Apr 2024) 4 | 2.74M |
| Short ratio (15 Apr 2024) 4 | 11.01 |
| Short % of float (15 Apr 2024) 4 | 13.80% |
| Short % of shares outstanding (15 Apr 2024) 4 | 12.97% |
| Shares short (prior month 15 Mar 2024) 4 | 2.41M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Sept 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -187.77% |
| Operating margin (ttm) | -193.78% |
Management effectiveness
| Return on assets (ttm) | -22.89% |
| Return on equity (ttm) | -56.11% |
Income statement
| Revenue (ttm) | 73.62M |
| Revenue per share (ttm) | 3.50 |
| Quarterly revenue growth (yoy) | -23.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -139.58M |
| Net income avi to common (ttm) | -138.24M |
| Diluted EPS (ttm) | -6.57 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 337.15M |
| Total cash per share (mrq) | 15.94 |
| Total debt (mrq) | 215.04M |
| Total debt/equity (mrq) | 112.07% |
| Current ratio (mrq) | 6.25 |
| Book value per share (mrq) | 9.07 |
Cash flow statement
| Operating cash flow (ttm) | -92.5M |
| Levered free cash flow (ttm) | -51.68M |
© 2024 Yahoo. All rights reserved.